Dr. Lawrence S. Feigenbaum, MD

Dr. Feigenbaum practices at Mid-County Dermatology, Inc in Saint Louis, Missouri.

Dr. Feigenbaum's NPI, 1851633242, was assigned on March 23, 2013. Dr. Feigenbaum holds Missouri license 2017002762.

Dr. Feigenbaum's primary practice is Mid-County Dermatology, Inc, at 3009 N Ballas Rd, Saint Louis, MO 63131 in Saint Louis County. The practice phone is (314) 994-0200.

Dr. Feigenbaum's primary practice is Mid-County Dermatology, Inc in Saint Louis, Missouri. Dr. Feigenbaum is also affiliated with Missouri Baptist Medical Center. The medical group on file is Mid-County Dermatology. Dmand AI also links Dr. Feigenbaum to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feigenbaum practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Feigenbaum's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Feigenbaum is licensed in Missouri.

CMS data shows 5,360 Medicare services from Dr. Feigenbaum across 22 procedure codes in 2024, for 1,112 Medicare patients. Medicare paid $371,610 for them. Every service was in an office.

CMS counts 1,112 Medicare patients who saw Dr. Feigenbaum in 2024. The largest group is 65 to 74, with 479 patients. 73% of them have high cholesterol, and 66% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feigenbaum's median patient age at 68, with 57% women.

In 2024, Dr. Feigenbaum wrote 1,533 Medicare Part D claims for 544 patients. 96% of them were for generic drugs. CMS names the drug for 1,347 of them, across 24 drugs with 11 or more claims each, at $21,542 in total drug cost. In 2023, CMS named 1,141 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Feigenbaum for performance year 2024, reported individually. Dr. Feigenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 915 procedures of removal of skin lesions by Dr. Feigenbaum, more than 92% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Feigenbaum, published from 2016 to 2017. Dr. Feigenbaum's most frequent co-authors are Kiran Motaparthi, MD, Rajiv I. Nijhawan, MD and Divya Srivastava, MD.

CMS Open Payments shows 999 general payments to Dr. Feigenbaum from 47 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Amgen Inc. paid the most, $23,557.